LAVA Therapeutics N.V. (LVTX) - Stock Prices, Stock Peers & Analysis

Home
LVTX

Company Name	LAVA Therapeutics N.V.
Symbol	LVTX
Currency	USD
Price	1.68
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	44,170,896
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.131 - 6.47
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Stephen Allen Hurly M.B.A., M.Sc.
Website	https://www.lavatherapeutics.com

An error occurred while fetching data.

About LAVA Therapeutics N.V.

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients.